You can find the annual or quarterly income statement of Crescent Biopharma Ord Shs here for insights into the performance and operational efficiency of Crescent Biopharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q3

Total revenue

--1.04M

----

Revenue

--1.04M

----

Operating expenses

--25.77M

--25.89M

R&D expenses

--17.90M

--20.35M

Depreciation, depletion, and amortization

--64.00K

--28.00K

Operating profit

---24.73M

---25.89M

Net non-operating interest income (expenses)

Non-operating interest income

--1.45M

--1.28M

Non-operating interest expense

--0.00

Income before tax

---23.28M

---24.61M

Income tax

--0.00

Income after tax

---23.28M

---24.61M

Net income from continuous operations

---23.28M

---24.61M

Net income attributable to controlling interests

---23.28M

---24.61M

Net income attributable to common shareholders

---23.28M

---24.61M

Basic earnings per share

---0.84

---1.49

Diluted earnings per share

---0.84

---1.49

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

